Read + Share
Khattak MN, Chichura AM, Lang JE. Adjuvant Trastuzumab Emtansine Versus Paclitaxel and Trastuzumab in Stage I
HER2-Positive Breast Cancer: The ATEMPT Trial. Ann Surg Oncol 2023 Dec 21. doi: 10.1245/s10434-023-14766.
PMID: 38127215
|
 |
|
Khattak MN, Chichura AM, Lang JE. Adjuvant Trastuzumab Emtansine Versus Paclitaxel and Trastuzumab in Stage I
HER2-Positive Breast Cancer: The ATEMPT Trial. Ann Surg Oncol 2023 Dec 21. doi: 10.1245/s10434-023-14766.
PMID: 38127215
|
|
|
|